- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Interleukin-17A in Psoriatic Disease
Authors
Keywords
Psoriasis, Ankylose Spondylitis, Zoledronic Acid, Denosumab, Ustekinumab
Journal
BIODRUGS
Volume 28, Issue 6, Pages 487-497
Publisher
Springer Nature
Online
2014-06-02
DOI
10.1007/s40259-014-0098-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brodalumab (AMG-827)
- (2014) Z. Gajdosik DRUGS OF THE FUTURE
- Lack of Anti-drug Antibodies in Patients with Psoriasis Well-controlled on Long-term Treatment with Tumour Necrosis Factor Inhibitors
- (2013) M Meyer et al. ACTA DERMATO-VENEREOLOGICA
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
- (2013) M. Esposito et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases
- (2013) Xinyang Song et al. CELLULAR SIGNALLING
- Dynamic regulatory network controlling TH17 cell differentiation
- (2013) Nir Yosef et al. NATURE
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials
- (2013) Andrew D. Dick et al. OPHTHALMOLOGY
- Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis
- (2013) Masaki Katayama et al. PLoS One
- Absence of Interleukin-17 Receptor A Signaling Prevents Autoimmune Inflammation of the Joint and Leads to a Th2-like Phenotype in Collagen-Induced Arthritis
- (2013) Odilia B. J. Corneth et al. Arthritis & Rheumatology
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of IL-17A blockade with secukinumab in autoimmune diseases
- (2012) Dhavalkumar D Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriasis: rationale for targeting interleukin-17
- (2012) G. Girolomoni et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
- (2012) Shu Zhu et al. CLINICAL SCIENCE
- Interactions between Inflammation and Coagulation in Autoimmune and Immune-Mediated Skin Diseases
- (2012) Angelo V. Marzano et al. Current Vascular Pharmacology
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update
- (2012) Alexander Nast et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Novel systemic drugs under investigation for the treatment of psoriasis
- (2012) Johann E. Gudjonsson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management
- (2012) A. Russolillo et al. RHEUMATOLOGY
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis
- (2012) Matthew S Doyle et al. ARTHRITIS RESEARCH & THERAPY
- Recent advances in the IL-17 cytokine family
- (2011) Sarah L Gaffen CURRENT OPINION IN IMMUNOLOGY
- IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
- (2011) Danuta Gutowska-Owsiak et al. EXPERIMENTAL DERMATOLOGY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Life before Seventeen: Cloning of the IL-17 Receptor
- (2011) S. L. Gaffen JOURNAL OF IMMUNOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2011) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety of treatment with biologics for psoriasis in daily practice: 5-year data
- (2011) P.P.M. van Lümig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The IL-17 pathway as a major therapeutic target in autoimmune diseases
- (2010) Yan Hu et al. Annals of the New York Academy of Sciences
- Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis
- (2010) Cristina Albanesi et al. AUTOIMMUNITY
- Interleukin-17 and its expanding biological functions
- (2010) Sheng Xu et al. Cellular & Molecular Immunology
- Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
- (2010) Kiyoshi Hirahara et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The IL-17 Family Cytokines in Immunity and Disease
- (2010) Rajita Pappu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-17 Amplifies Human Contact Hypersensitivity by Licensing Hapten Nonspecific Th1 Cells to Kill Autologous Keratinocytes
- (2010) D. Pennino et al. JOURNAL OF IMMUNOLOGY
- 8-Methoxypsoralen Plus Ultraviolet A Therapy Acts via Inhibition of the IL-23/Th17 Axis and Induction of Foxp3+ Regulatory T Cells Involving CTLA4 Signaling in a Psoriasis-Like Skin Disorder
- (2010) T. P. Singh et al. JOURNAL OF IMMUNOLOGY
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans
- (2010) S. Kagami et al. JOURNAL OF IMMUNOLOGY
- Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial
- (2010) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
- (2010) Thomas Dörner et al. PHARMACOLOGY & THERAPEUTICS
- Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?
- (2010) D. P. C. de Rooy et al. RHEUMATOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Signal transduction and Th17 cell differentiation
- (2009) John J. O'Shea et al. MICROBES AND INFECTION
- IL-17 and Th17 cells in human inflammatory diseases
- (2009) Pierre Miossec MICROBES AND INFECTION
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Immunopathogenesis of Rheumatoid Arthritis
- (2008) John B. Imboden Annual Review of Pathology-Mechanisms of Disease
- An overview of IL-17 function and signaling
- (2008) Sarah L. Gaffen CYTOKINE
- IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response
- (2008) Kilian Eyerich et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Differentiation of human TH-17 cells does require TGF-β!
- (2008) Anne O'Garra et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation